Agenus Inc. (AGEN) Income Statement

Revenue climbed from $23.5M in 2024Q2 to $34.5M in 2026Q2, a cumulative increase of roughly 47% over eight quarters. The acceleration appears driven by commercial revenue scaling rather than acquisition effects, given the steady sequential growth in 2025Q3 through 2026Q2 ($30.2M → $34.2M → $33.7M → $34.5M). However, the low absolute base means percentage growth rates overstate the dollar impact, and durability hinges on whether the current commercial mix can sustain momentum without relying on episodic COGS-related adjustments.

Unlike peers Exelixis (96.4% gross margin) and Incyte (92.8%) whose margins are stable, Agenus's reported COGS has swung from $41.2M to $583K across consecutive quarters, which suggests the cost line captures episodic charges — likely milestone or product-related payments — rather than recurring manufacturing economics. This variability means gross margin cannot be used as a reliable forward indicator of pricing power or unit economics. Investors should scrutinize the underlying nature of these COGS swings to determine whether the recent high-margin quarters reflect a durable structural shift or simply timing of cost recognition.

The operating margin trajectory moved from -117.4% (2024Q1) to +32.7% (2026Q2), representing a $44M+ quarterly swing in operating result. The leverage appears primarily cost-driven — SG&A fell 41% from 2024Q4 to 2026Q2 — rather than purely revenue-driven, as revenue growth of 29% over the same period is meaningful but insufficient alone to explain the swing. Critically, R&D has also fallen from $43.9M (2024Q1) to $14.8M (2026Q2), which suggests the operating leverage may partly reflect reduced pipeline investment rather than genuine operating efficiency; investors should weigh whether lower R&D spending today trades off against future pipeline productivity.

The inflection appears to have two distinct legs: a 41% year-over-year reduction in SG&A and a normalization of COGS from $33.9M (2024Q4) to $7.5M (2025Q4). Since then, operating income has held positive for three consecutive quarters ($14.4M → $15.1M → $11.3M), suggesting the turnaround is not a one-period anomaly but may reflect a durable cost structure reset. However, 2025Q4 still produced a net loss of -$10.6M despite positive operating income, indicating non-operating losses offset the core gain; the lasting impact of this inflection depends on whether the lower cost base persists while revenue continues its current growth trajectory.